TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-135.32M
↓ 116% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-62.60M
Historical baseline
PeriodValueYoY Change
TTM$-135.32M-22.1%
2024$-110.82M-80.6%
2023$-61.36M+7.7%
2022$-66.50M-36.6%
2021$-48.68M-1510.2%
2020$-3.02M+75.9%
2019$-12.52M-